Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey

Aylin Babalık (Istanbul, Turkey), Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan

Source: International Congress 2015 – Management of TB: a patient focus
Session: Management of TB: a patient focus
Session type: Thematic Poster Session
Number: 2742
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Aylin Babalık (Istanbul, Turkey), Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan. Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey. Eur Respir J 2015; 46: Suppl. 59, 2742

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predisposing factors of multi drug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia in 2009-2012
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


Indicators of rifampicin-resistant TB response in Belarus, 2009-2014
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012)
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Factors associated with tuberculosis among prisoners in Bulgaria for the period 2004-2013
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Risk factors for anti-TB drug resistance in Poland
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

Fifteen years period (2000-2014) of resistant TB forms in Vojvodina (Serbia)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Analysis of TB denotifications in North London (2003 – 2012)
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013


Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Predictive factors for recurrent tuberculosis in Iasi County, Romania: Retrospective study 2002-2011
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


TB epidemiology and drug resistance in Bulgaria (1990-2003)
Source: Eur Respir J 2004; 24: Suppl. 48, 199s
Year: 2004

Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Transmission pattern of MDR-TB in Singapore 2005-2015
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Current status of fluoroquinolone use for treatment of tuberculosis in Korea
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013